Structure |
Chemical Name |
CAS |
MF |
![Bisoprolol Impurity 41](/) |
Bisoprolol Impurity 41 |
|
|
![1,4-Naphthalenedione, 2-(3-hydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraenyl)-3-methyl-, (,E,E)- (9CI)](/CAS/20211123/GIF/65061-22-5.gif) |
1,4-Naphthalenedione, 2-(3-hydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraenyl)-3-methyl-, (,E,E)- (9CI) |
65061-22-5 |
C31H40O3 |
![Piperacilin](/) |
Piperacilin |
|
|
![Varenicline Impurity D](/) |
Varenicline Impurity D |
1002359-81-0 |
|
![2-Propanone, 1-(2-hydroxypropoxy)- (9CI)](/CAS/GIF/90817-38-2.gif) |
2-Propanone, 1-(2-hydroxypropoxy)- (9CI) |
90817-38-2 |
C6H12O3 |
![Nirmatrelvir Impurity 4](/) |
Nirmatrelvir Impurity 4 |
|
|
![Nifedipine Impurity L](/) |
Nifedipine Impurity L |
|
|
![2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI)](/CAS/GIF/155102-96-8.gif) |
2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI) |
155102-96-8 |
C5H9NO4 |
![Bumetanide Impurity 24](/) |
Bumetanide Impurity 24 |
|
|
![Rocuronium Bromide Impurity 37、38、39](/) |
Rocuronium Bromide Impurity 37、38、39 |
|
|
![Ritonavir EP Impurity HIJ](/) |
Ritonavir EP Impurity HIJ |
|
|
![Crisaborole Impurity 42](/) |
Crisaborole Impurity 42 |
|
|
![Perospirone Impurity 26](/) |
Perospirone Impurity 26 |
|
|
![Paxlovid Impurity 15](/) |
Paxlovid Impurity 15 |
|
|
![3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide](/) |
3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
![Canagliflozin Impurity 84](/) |
Canagliflozin Impurity 84 |
|
|
![Fondaparinux sodium impurity 18](/) |
Fondaparinux sodium impurity 18 |
|
|
![Fondaparinux sodium impurity 13](/) |
Fondaparinux sodium impurity 13 |
|
|
![Lasmiditan Impurity 1](/) |
Lasmiditan Impurity 1 |
|
|
![(5R,6R)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one](/) |
(5R,6R)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one |
|
|
![Olodaterol Impurity 22](/) |
Olodaterol Impurity 22 |
|
|
![Olodaterol Impurity 25](/) |
Olodaterol Impurity 25 |
|
|
![32,43,50-Tricarboxy-cyanoco balamin](/) |
32,43,50-Tricarboxy-cyanoco balamin |
|
|
![(S)-Azelastine](/CAS/GIF/143228-85-7.gif) |
(S)-Azelastine |
143228-85-7 |
C22H24ClN3O |
![Relugolix Impurity 92](/) |
Relugolix Impurity 92 |
|
|
![N-Desethyl Vardenafil](/CAS/GIF/448184-46-1.gif) |
N-Desethyl Vardenafil |
448184-46-1 |
C21H28N6O4S |
![O-デスメチルゲフィチニブ](/CAS/GIF/847949-49-9.gif) |
O-デスメチルゲフィチニブ |
847949-49-9 |
C21H22ClFN4O3 |
![N-デメチルシルデナフィルピラゾール](/CAS/GIF/139755-95-6.gif) |
N-デメチルシルデナフィルピラゾール |
139755-95-6 |
C21H28N6O4S |
![S-(-)-Tolterodine](/CAS/GIF/124937-53-7.gif) |
S-(-)-Tolterodine |
124937-53-7 |
C22H31NO |
![ゾルミトリプタンN-オキシド](/CAS/GIF/251451-30-6.gif) |
ゾルミトリプタンN-オキシド |
251451-30-6 |
C16H21N3O3 |
![3-(hydroxymethyl)-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/) |
3-(hydroxymethyl)-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
|
![7-CHLORO-1,3DIHYDRO-5-FLUOROPHENYL-2-NITRO-METHYLENE-2H-1,4-BENZODIAZEPINE-4-OXIDE](/CAS/GIF/60656-76-0.gif) |
7-CHLORO-1,3DIHYDRO-5-FLUOROPHENYL-2-NITRO-METHYLENE-2H-1,4-BENZODIAZEPINE-4-OXIDE |
60656-76-0 |
C16H11ClFN3O3 |
![(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン](/CAS/GIF/80657-17-6.gif) |
(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン |
80657-17-6 |
C18H22O2 |
![2-デオキシテトロン酸](/CAS/GIF/1518-61-2.gif) |
2-デオキシテトロン酸 |
1518-61-2 |
C4H8O4 |
![シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]]](/CAS/GIF/59865-16-6.gif) |
シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]] |
59865-16-6 |
C62H111N11O12 |
![GINKGOLIC ACIDS](/) |
GINKGOLIC ACIDS |
|
|
![(R)-ズロキセチン塩酸塩](/CAS/GIF/910138-96-4.gif) |
(R)-ズロキセチン塩酸塩 |
910138-96-4 |
C18H20ClNOS |
![(R)-テラゾシン](/CAS/GIF/109351-34-0.gif) |
(R)-テラゾシン |
109351-34-0 |
C19H25N5O4 |
![(1S,4R)-4-アミノ-2-シクロペンテン-1-カルボン酸メチル](/CAS/GIF/138923-03-2.gif) |
(1S,4R)-4-アミノ-2-シクロペンテン-1-カルボン酸メチル |
138923-03-2 |
C7H11NO2 |
![L-Alanine,propylester(9CI)](/CAS/GIF/58989-06-3.gif) |
L-Alanine,propylester(9CI) |
58989-06-3 |
C6H13NO2 |
![N-hydroxyphenetidine](/CAS/GIF/38246-95-6.gif) |
N-hydroxyphenetidine |
38246-95-6 |
|
![1-エチル-3-カルボキシ-6-フルオロ-1,4-ジヒドロ-7-(4-メチルピペラジノ)-4-オキソキノリン1-オキシド](/CAS/GIF/85145-21-7.gif) |
1-エチル-3-カルボキシ-6-フルオロ-1,4-ジヒドロ-7-(4-メチルピペラジノ)-4-オキソキノリン1-オキシド |
85145-21-7 |
C17H20FN3O4 |
![2,3-ジメチル-1,4-ナフトキノン](/CAS/GIF/2197-57-1.gif) |
2,3-ジメチル-1,4-ナフトキノン |
2197-57-1 |
C12H10O2 |
![Rosuvastatin Impurity 145](/) |
Rosuvastatin Impurity 145 |
|
|
![Peramivir Intermediate impurity 1](/) |
Peramivir Intermediate impurity 1 |
|
|
![Rosuvastatin EP Impurity G](/) |
Rosuvastatin EP Impurity G |
|
|
![Peramivir Intermediate Impurity 43](/) |
Peramivir Intermediate Impurity 43 |
|
|
![Peramivir Deacetylated Impurity](/) |
Peramivir Deacetylated Impurity |
|
|
![Linagliptin Impurity 49](/) |
Linagliptin Impurity 49 |
|
|
![Solifenacin Related CoMpound 2 Succinate](/CAS/20211123/GIF/1262506-09-1.gif) |
Solifenacin Related CoMpound 2 Succinate |
1262506-09-1 |
C27H32N2O6 |
![Tetrahydro FuroseMide](/CAS/20150408/GIF/4793-38-8.gif) |
Tetrahydro FuroseMide |
4793-38-8 |
C12H15ClN2O5S |
![6-O-DesMethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride](/CAS/20211123/GIF/183320-04-9.gif) |
6-O-DesMethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride |
183320-04-9 |
C21H21Cl2N3O3 |
![Macitentan IMpurity](/CAS/20180906/GIF/556796-88-4.gif) |
Macitentan IMpurity |
556796-88-4 |
C17H15Br2N5O4S |
![4-((4-broMophenyl)(1H-1,2,4-triazol-1-yl)Methyl)benzonitrile](/CAS/20150408/GIF/143030-54-0.gif) |
4-((4-broMophenyl)(1H-1,2,4-triazol-1-yl)Methyl)benzonitrile |
143030-54-0 |
C16H11BrN4 |
![Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]-](/CAS/20150408/GIF/83881-53-2.gif) |
Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]- |
83881-53-2 |
C21H26N2O3 |
![Benazepril Related CoMpound B](/) |
Benazepril Related CoMpound B |
|
|
![IMatinib iMpurity](/CAS/20210111/GIF/152459-96-6.gif) |
IMatinib iMpurity |
152459-96-6 |
C24H21N5O |
![(2R,3R,4R,5S,6R)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](/CAS/20150408/GIF/CB92715716.gif) |
(2R,3R,4R,5S,6R)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
|
C32H33FO9S |
![1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1365267-36-2.gif) |
1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1365267-36-2 |
C36H36N6O10 |
![(4-メチルキナゾリン-2-イル)メタノール](/CAS/20150408/GIF/13535-91-6.gif) |
(4-メチルキナゾリン-2-イル)メタノール |
13535-91-6 |
C10H10N2O |
![5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one](/CAS/20150408/GIF/452340-96-4.gif) |
5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one |
452340-96-4 |
C13H15NO4 |
![alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride](/CAS/20150408/GIF/104743-23-9.gif) |
alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride |
104743-23-9 |
C12H20ClNO |
![N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide](/CAS/20150408/GIF/177216-32-9.gif) |
N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide |
177216-32-9 |
C18H25N5O7 |
![5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1)](/CAS/20180808/GIF/64372-43-6.gif) |
5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) |
64372-43-6 |
C21H23BrFNO5 |
![(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine](/CAS/20150408/GIF/1070876-09-3.gif) |
(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine |
1070876-09-3 |
C28H26N6S2 |
![(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate](/CAS/20150408/GIF/1187479-72-6.gif) |
(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate |
1187479-72-6 |
C29H45BN2O5 |
![Posaconazole iMpurity 7](/CAS/20211123/GIF/2180759-84-4.gif) |
Posaconazole iMpurity 7 |
2180759-84-4 |
C37H42F2N8O4 |
![Intedanib Impurity](/CAS/20210305/GIF/2243396-74-7.gif) |
Intedanib Impurity |
2243396-74-7 |
C31H32N6O6 |
![Donepezil Impurity 3](/CAS/20180703/GIF/1023500-88-0.gif) |
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
![Fesoterodine Related Impurity 4](/CAS/20200515/GIF/214601-12-4.gif) |
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
![Prasugrel Impurity 14 Maleate](/CAS/20180808/GIF/1373350-60-7.gif) |
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
![Sofosbuvir Impurity 32](/CAS/20180808/GIF/1157884-58-6.gif) |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
![Torsemide Related Compound 1](/CAS/20200515/GIF/947327-54-0.gif) |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
![Vortioxetine Impurity 3](/CAS/20180808/GIF/508233-82-7.gif) |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
![CYCLOPENTYL BENZOATE](/CAS/20180703/GIF/32651-38-0.gif) |
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
![4,5-ジクロロチオフェン-2-カルボン酸](/CAS/GIF/31166-29-7.gif) |
4,5-ジクロロチオフェン-2-カルボン酸 |
31166-29-7 |
C5H2Cl2O2S |
![N,O-Dibenzylated formoterol](/CAS/GIF/43229-70-5.gif) |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
![Entacapone](/) |
Entacapone |
|
|
![nifedipine iMpurity](/CAS/20180703/GIF/CB93033129.gif) |
nifedipine iMpurity |
|
C19H22N2O6 |
![Linagliptin Impurity A](/) |
Linagliptin Impurity A |
|
|
![Dehydropitavastatin ethyl ester](/CAS/20210111/GIF/254452-91-0.gif) |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
![(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide](/CAS/20180703/GIF/357338-13-7.gif) |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
![Linagliptin Impurity V](/) |
Linagliptin Impurity V |
|
|
![methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate](/CAS/20180703/GIF/1181267-33-3.gif) |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
![(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol](/CAS/20180703/GIF/150194-52-8.gif) |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
![Etoricoxib Impurity 18](/) |
Etoricoxib Impurity 18 |
|
|
![Ibrutinib Impurity 4](/CAS/20210111/GIF/1807619-68-6.gif) |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
![Imatinib Impurity 3](/) |
Imatinib Impurity 3 |
|
|
![Mirabegron Impurity 16](/) |
Mirabegron Impurity 16 |
|
|
![Olaparib Impurity 2](/) |
Olaparib Impurity 2 |
|
|
![Sofosbuvir Impurity 7](/CAS/20200611/GIF/1884385-12-9.gif) |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
![Vonoprazan Impurity 3](/CAS/20200611/GIF/928325-41-1.gif) |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
![Cinacalcet Impurity 22](/) |
Cinacalcet Impurity 22 |
|
|
![Dapagliflozin Impurity C](/) |
Dapagliflozin Impurity C |
|
|
![Dasatinib Impurity E](/) |
Dasatinib Impurity E |
|
|
![Ixazomib Impurity](/) |
Ixazomib Impurity |
|
|
![Nevirapine Impurity](/) |
Nevirapine Impurity |
|
|
![Omarigliptin Impurity](/CAS/20210111/GIF/1819364-01-6.gif) |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
![Palbociclib Impurity 8](/CAS/20180808/GIF/827022-31-1.gif) |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |